Literature DB >> 28091735

Comprehensive assessment of peripheral blood TCRβ repertoire in infectious mononucleosis and chronic active EBV infection patients.

Shenglin Liu1, Qian Zhang2, Dongli Huang3, Wenli Zhang2, Fengluan Zhong2, Jia Feng2, Xueru Chen2, Qingxiang Meng2, Xiaofan Chen1, Wei Zhang4, Hongyu Zhang5.   

Abstract

Epstein-Barr virus (EBV) primary infection is usually asymptomatic, but it sometimes progresses to infectious mononucleosis (IM). Occasionally, some people develop chronic active EBV infection (CAEBV) with underlying immunodeficiency, which belongs to a continuous spectrum of EBV-associated lymphoproliferative disorders (EBV+ LPD) with heterogeneous clinical presentations and high mortality. It has been well established that T cell-mediated immune response plays a critical role in the disease evolution of EBV infection. Recently, high-throughput sequencing of the hypervariable complementarity-determining region 3 (CDR3) segments of the T cell receptor (T cell receptor β (TCRβ)) has emerged as a sensitive approach to assess the T cell repertoire. In this study, we fully characterized the diversity of peripheral blood TCRβ repertoire in IM (n = 6) and CAEBV patients (n = 5) and EBV-seropositive controls (n = 5). Compared with the healthy EBV-seropositive controls, both IM and CAEBV patients demonstrate a significant decrease in peripheral blood TCRβ repertoire diversity, basically, including narrowed repertoire breadth, highly expanded clones, and skewed CDR3 length distribution. However, there is no significant difference between IM and CAEBV patients. Furthermore, we observed some disease-related preferences in TRBV/TRBJ usage and combinations, as well as lots of T cell clones shared by different groups (unique or overlapped) involved in public T cell responses, which provide more detailed insights into the divergent disease evolution.

Entities:  

Keywords:  Chronic active EBV infection (CAEBV); Epstein-Barr virus (EBV); Infectious mononucleosis (IM); T cell receptor (TCRβ) repertoire complementarity-determining region 3 (CDR3)

Mesh:

Substances:

Year:  2017        PMID: 28091735     DOI: 10.1007/s00277-016-2911-8

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   3.673


  4 in total

1.  A comprehensive immune repertoire study for patients with pulmonary tuberculosis.

Authors:  Yingyun Fu; Bo Li; Yazhen Li; Minlian Wang; Yongjian Yue; Lan Xu; Shulin Li; Qijun Huang; Song Liu; Yong Dai
Journal:  Mol Genet Genomic Med       Date:  2019-06-07       Impact factor: 2.183

2.  Dynamic analysis of peripheral blood TCR β-chain CDR3 repertoire in occupational medicamentosa-like dermatitis due to trichloroethylene.

Authors:  Dafeng Lin; Dianpeng Wang; Peimao Li; Xiangli Yang; Wei Liu; Lu Huang; Zhimin Zhang; Yanfang Zhang; Wen Zhang; Naixing Zhang; Ming Zhang; Xianqing Huang
Journal:  Sci Rep       Date:  2021-05-11       Impact factor: 4.379

Review 3.  Chronic Active Epstein-Barr Virus Disease.

Authors:  Hiroshi Kimura; Jeffrey I Cohen
Journal:  Front Immunol       Date:  2017-12-22       Impact factor: 7.561

4.  A distinct subtype of Epstein-Barr virus-positive T/NK-cell lymphoproliferative disorder: adult patients with chronic active Epstein-Barr virus infection-like features.

Authors:  Keisuke Kawamoto; Hiroaki Miyoshi; Takaharu Suzuki; Yasuji Kozai; Koji Kato; Masaharu Miyahara; Toshiaki Yujiri; Ilseung Choi; Katsumichi Fujimaki; Tsuyoshi Muta; Masaaki Kume; Sayaka Moriguchi; Shinobu Tamura; Takeharu Kato; Hiroyuki Tagawa; Junya Makiyama; Yuji Kanisawa; Yuya Sasaki; Daisuke Kurita; Kyohei Yamada; Joji Shimono; Hirohito Sone; Jun Takizawa; Masao Seto; Hiroshi Kimura; Koichi Ohshima
Journal:  Haematologica       Date:  2017-12-14       Impact factor: 9.941

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.